Centro de Investigaciones Biológicas-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2017

  1. Doxorubicin and edelfosine lipid nanoparticles are effective acting synergistically against drug-resistant osteosarcoma cancer cells

    Cancer Letters, Vol. 388, pp. 262-268

2015

  1. Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types

    Journal of the National Cancer Institute, Vol. 107, Núm. 12